Loading clinical trials...

Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant | Clinical Trials | Clareo Health

COMPLETEDPhase 2

Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant

A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected With Chronic HCV Who Have Advanced Liver Disease or Are Post-Liver Transplant

NCT02010255•Gilead Sciences

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Chronic HCV Infection

Interventions

LDV/SOF

RBV

Locations

34

Australia

Locations (34)

Royal Prince Alfred Hospital, University of Sydney

Camperdown, New South Wales, Australia

Austin Repatriation Hospital (Melbourne) // Victorian Transplant Centre

Heidelberg, Victoria, Australia

Medizinische Universitaet Innsbruck

Innsbruck, Austria

Medizinische Universitat Wien

Vienna, Austria

UCL St-Luc Brussels

Brussels, Belgium

Universitair Ziekenhuis Gent

Ghent, Belgium

Key Dates

Start Date

January 1, 2014

Primary Completion Date

May 1, 2015

Completion Date

August 1, 2015

Last Updated

November 19, 2018

Related Studies

COMPLETEDPhase 2

Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV Infection

NCT01984294

Chronic HCV Infection

COMPLETEDPhase 2

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders

NCT02120300

Chronic HCV Infection

Sponsors

Lead Sponsor

Gilead Sciences

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 19, 2018Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions